Indivior appoints Mark Crossley as CEO

Indivior has promoted Mark Crossley to the role of chief executive officer, succeeding Shaun Thaxter.

Crossley, who has been chief financial and operations officer at Indivior since February 2017, was chief strategy officer from 2014 to 2017 and served as finance director, leading the demerger of Indivior from its former parent.

Prior to joining the company in 2012, he spent 13 years at Procter & Gamble in various finance leadership positions and eight years as an officer in the United States Coast Guard.

Shaun Thaxter is stepping down stepping down by mutual agreement with the board.

Meanwhile, Ryan Preblick, currently senior vice president of Global Financial Planning and Analysis Commercial Operations, has been appointed interim CFO.

Indivior, which makes opioid addiction treatment product Suboxone Film, said it will initiate a search for a permanent CFO and will assess whether to appoint a separate operations officer.

Crossley said: "There remains a very significant opportunity for Indivior in the years ahead, and I look forward to working with the board to deliver the full potential of our key assets, to resolve outstanding investigations and litigations as expeditiously as possible, and to ensure that we continue to play a leading role in helping patients, doctors, and communities fight the human crisis of opioid addiction."